Kidney histologic alterations in α-galactosidase-deficient mice

Virchows Archiv

Volumn 458, Issue 4, 2011, Pages 477-486

  Valbuena, Carmen ^a,e   Oliveira, João Paulo ^a,b   Carneiro, Fátima ^c   Relvas, Sandra ^a   Ganhão, Mariana ^a   Sá Miranda, M Clara ^d   Rodrigues, Lorena G ^d  

^a HOSPITAL DE SÃO JOÃO   (Portugal)

^b Inst of Pharmacol and Therapeutics   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

^d UNIVERSITY OF PORTO   (Portugal)

^e University of Porto   (Portugal)

Author keywords

galactosidase deficient mice; Fabry disease; Glycosphingolipids; Histology; Kidney; Score

Indexed keywords

ALPHA GALACTOSIDASE; GLYCOSPHINGOLIPID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL TYPE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; FABRY DISEASE; FEMALE; GLOMERULOSCLEROSIS; HISTOPATHOLOGY; KIDNEY; KIDNEY CELL; KIDNEY PARENCHYMA; KIDNEY PROXIMAL TUBULE; MALE; MESANGIUM CELL; MOUSE; NONHUMAN; PODOCYTE; PREVALENCE; PRIORITY JOURNAL; SCORING SYSTEM;

ANIMALS; DISEASE MODELS, ANIMAL; FABRY DISEASE; FEMALE; HUMANS; INCLUSION BODIES; KIDNEY; MALE; MICE; MICE, KNOCKOUT;

EID: 79956224824     PISSN: 09456317     EISSN: 14322307     Source Type: Journal    
DOI: 10.1007/s00428-011-1051-8     Document Type: Article

References (33)

1. Bishop DF, Kornreich R, Desnick RJ (1988) Structural organization of the human alpha-galactosidase A gene: further evidence for the absence of a 3′ untranslated region. Proc Natl Acad Sci USA 85:3903-3907
2. Brady RO, Gal AE, Bradley RM, Martensson E, Warshaw AL, Laster L (1967) Enzymatic defect in Fabry's disease. Ceramide-trihexosidase deficiency. N Engl J Med 276:1163-1167
3. Kint JA (1970) Fabry's disease: alpha-galactosidase deficiency. Science 167:1268-1269
4. Desnick RJ, Ioannou YA, Eng CM (2001) Alpha-Galactosidase A deficiency: Fabry disease. In: Scriver C, Beaudet A, Sly W, Valle D (eds) The metabolic bases of inherited disease, 8th edn. McGraw-Hill, New York, pp 3733-3774
5. Desnick RJ, Brady R, Barranger J, Collins AJ, Germain DP, Goldman M, Grabowski G, Packman S, Wilcox WR (2003) Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann Intern Med 138:338-346 (Pubitemid 36205932)
6. Branton MH, Schiffmann R, Sabnis SG, Murray GJ, Quirk JM, Altarescu G, Goldfarb L, Brady RO, Balow JE, Austin Iii HA, Kopp JB (2002) Natural history of Fabry renal disease: influence of alpha-galactosidase A activity and genetic mutations on clinical course. Medicine 81:122-138 (Pubitemid 34218568)
7. Schiffmann R, Warnock DG, Banikazemi M, Bultas J, Linthorst GE, Packman S, Sorensen SA, Wilcox WR, Desnick RJ (2009) Fabry disease: progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy. Nephrol Dial Transplant 24:2102-2111
8. Gubler MC, Lenoir G, Grunfeld JP, Ulmann A, Droz D, Habib R (1978) Early renal changes in hemizygous and heterozygous patients with Fabry's disease. Kidney Int 13:223-235 (Pubitemid 8304328)
9. Sessa A, Meroni M, Battini G, Maglio A, Brambilla PL, Bertella M, Nebuloni M, Pallotti F, Giordano F, Bertagnolio B, Tosoni A (2001) Renal pathological changes in Fabry disease. J Inherit Metab Dis 24:66-70 (Pubitemid 33061634)
10. Alroy J, Sabnis S, Kopp JB (2002) Renal pathology in Fabry disease. J Am Soc Nephrol 13:S134-S138 (Pubitemid 34579224)
11. Sessa A, Toson A, Nebuloni M, Pallotti F, Giordano F, Battini G, Maglio A, Meroni M, Calconi G, Bertolone G, Gatti P (2002) Renal ultrastructural findings in Anderson-Fabry disease. J Nephrol 15:109-112 (Pubitemid 34594159)
12. Fischer EG, Moore MJ, Lager DJ (2006) Fabry disease: a morphologic study of 11 cases. Mod Pathol 19:1295-1301
13. Tøndel C, Bostad L, Hirth A, Svarstad E (2008) Renal biopsy findings in children and adolescents with Fabry disease and minimal albuminuria. Am J Kidney Dis 51:767-776 (Pubitemid 351626251)
14. Valbuena C, Carvalho E, Bustorff M, Ganhao M, Relvas S, Nogueira R, Carneiro F, Oliveira JP (2008) Kidney biopsy findings in heterozygous Fabry disease females with early nephropathy. Virchows Arch 453:329-338
15. Fogo AB, Bostad L, Svarstad E, Cook WJ, Moll S, Barbey F, Geldenhuys L, West M, Ferluga D, Vujkovac B, Howie AJ, Burns A, Reeve R, Waldek S, Noel LH, Grunfeld JP, Valbuena C, Oliveira JP, Muller J, Breunig F, Zhang X, Warnock DG (2010) Scoring system for renal pathology in Fabry disease: report of the International Study Group of Fabry Nephropathy (ISGFN). Nephrol Dial Transplant 25:2168-2177
16. Eng CM, Guffon N, Wilcox WR, Germain DP, Lee P, Waldek S, Caplan L, Linthorst GE, Desnick RJ (2001) Safety and efficacy of recombinant human alpha-galactosidase A - replacement therapy in Fabry's disease. N Engl J Med 345:9-16 (Pubitemid 32634266)
17. Schiffmann R, Kopp JB, Austin HA 3rd, Sabnis S, Moore DF, Weibel T, Balow JE, Brady RO (2001) Enzyme replacement therapy in Fabry disease: a randomized controlled trial. J Am Med Assoc 285:2743-2749 (Pubitemid 32525371)
18. Thurberg BL, Rennke H, Colvin RB, Dikman S, Gordon RE, Collins AB, Desnick RJ, O'Callaghan M (2002) Globotriaosylceramide accumulation in the Fabry kidney is cleared from multiple cell types after enzyme replacement therapy. Kidney Int 62:1933-1946 (Pubitemid 35366149)
19. Ohshima T, Murray GJ, Swaim WD, Longenecker G, Quirk JM, Cardarelli CO, Sugimoto Y, Pastan I, Gottesman MM, Brady RO, Kulkarni AB (1997) alpha-Galactosidase A deficient mice: a model of Fabry disease. Proc Natl Acad Sci USA 94:2540-2544 (Pubitemid 27136911)
20. Ohshima T, Schiffmann R, Murray GJ, Kopp J, Quirk JM, Stahl S, Chan CC, Zerfas P, Tao-Cheng JH, Ward JM, Brady RO, Kulkarni AB (1999) Aging accentuates and bone marrow transplantation ameliorates metabolic defects in Fabry disease mice. Proc Natl Acad Sci USA 96:6423-6427 (Pubitemid 29256681)
21. Ioannou YA, Zeidner KM, Gordon RE, Desnick RJ (2001) Fabry disease: preclinical studies demonstrate the effectiveness of alpha-galactosidase A replacement in enzyme-deficient mice. Am J Hum Genet 68:14-25 (Pubitemid 32048358)
22. Aerts JM, Groener JE, Kuiper S, Donker-Koopman WE, Strijland A, Ottenhoff R, van Roomen C, Mirzaian M, Wijburg FA, Linthorst GE, Vedder AC, Rombach SM, Cox-Brinkman J, Somerharju P, Boot RG, Hollak CE, Brady RO, Poorthuis BJ (2008) Elevated globotriaosylsphingosine is a hallmark of Fabry disease. Proc Natl Acad Sci USA 105:2812-2817 (Pubitemid 351723626)
23. Rodrigues LG, Ferraz MJ, Rodrigues D, Pais-Vieira M, Lima D, Brady RO, Sousa MM, Sa-Miranda MC (2009) Neurophysiological, behavioral and morphological abnormalities in the Fabry knockout mice. Neurobiol Dis 33:48-56
24. Eitzman DT, Bodary PF, Shen Y, Khairallah CG, Wild SR, Abe A, Shaffer-Hartman J, Shayman JA (2003) Fabry disease in mice is associated with age-dependent susceptibility to vascular thrombosis. J Am Soc Nephrol 14:298-302 (Pubitemid 36150852)
25. Shu L, Shayman JA (2007) Caveolin-associated accumulation of globotriaosylceramide in the vascular endothelium of alpha-galactosidase A null mice. J Biol Chem 282:20960-20967 (Pubitemid 47099942)
26. Park JL, Whitesall SE, D'Alecy LG, Shu L, Shayman JA (2008) Vascular dysfunction in the alpha-galactosidase A-knockout mouse is an endothelial cell-, plasma membrane-based defect. Clin Exp Pharmacol Physiol 35:1156-1163
27. Park JL, Shu L, Shayman JA (2009) Differential involvement of COX1 and COX2 in the vasculopathy associated with the alpha-galactosidase A-knockout mouse. Am J Physiol 296:H1133-H1140
28. Shu L, Park JL, Byun J, Pennathur S, Kollmeyer J, Shayman JA (2009) Decreased nitric oxide bioavailability in a mouse model of Fabry disease. J Am Soc Nephrol 20:1975-1985
29. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215
30. Conti CJ, Gimenez-Conti IB, Benavides F, Frijhoff AFW, Conti MA (reviewed by) Ward JM (2004) Atlas of Laboratory Mouse Histology. Texas Histopages, Inc. http://ctrgenpath.net/static/atlas/mousehistology. Accessed 2 January 2010
31. Warnock DG, Valbuena C, West M, Oliveira JP (2010) Renal manifestations of Fabry disease. In: Elstein D, Altarescu G, Beck M (eds) Fabry disease, 1st edn. Springer, Dordrecht, pp 211-244
32. Meehan SM, Junsanto T, Rydel JJ, Desnick RJ (2004) Fabry disease: renal involvement limited to podocyte pathology and proteinuria in a septuagenarian cardiac variant. Pathologic and therapeutic implications. Am J Kidney Dis 43:164-171 (Pubitemid 38049449)
33. Brosius FC (2010) Susceptible mice: identifying a diabetic nephropathy disease locus using a murine model. Kidney Int 78:431-432